Anne Marie Cook - 28 Nov 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role: SVP, GC & Secretary
Signature: /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Anne Marie Cook
Issuer symbol: SAGE
Transactions as of: 28 Nov 2023
Net transactions value: -$22,623
Form type: 4
Filing time: 30 Nov 2023, 16:04:26 UTC
Previous filing: 15 Feb 2023
Next filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAGE	Common Stock	Award	$0	+4,000	+37%	$0.000000	14,890	28 Nov 2023	Direct	F1, F2
transaction	SAGE	Common Stock	Tax liability	$22,623	-1,174	-7.9%	$19.27	13,716	28 Nov 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 10,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 4,000 shares.
F2	Reflects beneficial ownership balance which includes 392 shares purchased on June 30, 2023 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.